Catalyst Biosciences Reports Fourth Quarter and Full-Year 2017 Operating & Financial Results Pharmaceutical Investing
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2017 Financial Results Pharmaceutical Investing
Corium Announces Proposed Offering of $100 Million of Convertible Senior Notes Pharmaceutical Investing
Asterias Provides Update for its AST-OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury Biotech Investing
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2017 Financial Results Pharmaceutical Investing
Updated Pennsylvania Legislative Study Projects more than 90% Savings in Bay Compliance Costs Biotech Investing
Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness